The global Adoptive Cellular Immunotherapy market size was valued at US$ 3.45 billion in 2024 and is projected to reach US$ 8.91 billion by 2030, at a CAGR of 17.1% during the forecast period 2024-2030.
United States Adoptive Cellular Immunotherapy market size was valued at US$ 1.12 billion in 2024 and is projected to reach US$ 2.79 billion by 2030, at a CAGR of 16.4% during the forecast period 2024-2030.
Immunotherapy approach using patients' own immune cells to treat cancer and other diseases.
Rapid growth driven by increasing cancer prevalence and advancements in cell therapy technologies. Rising investment in CAR-T cell therapies and TIL treatments. Ongoing clinical trials expanding potential applications in various cancer types.
Report Overview
Adoptive cellular immunity is the transfer of lymphocytes from the donor to the recipient to enhance its cellular immunity.
This report provides a deep insight into the global Adoptive Cellular Immunotherapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Adoptive Cellular Immunotherapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Adoptive Cellular Immunotherapy market in any manner.
Global Adoptive Cellular Immunotherapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Amgen Inc
Autolus Therapeutics Plc
Beijing Immunochina Medical Science & Technology Co Ltd
Bellicum Pharmaceuticals Inc
Bristol-Myers Squibb Co
bluebird bio Inc
CARsgen Therapeutics Ltd
Celgene Corp
Cell Medica Ltd
Cellular Biomedicine Group Inc
Celularity Inc
Celyad SA
Daiichi Sankyo Co Ltd
Fosun Pharmaceutical AG
Gilead Sciences Inc
Guangzhou Anjie Biomedical Technology Co Ltd
Hangzhou Converd Co Ltd
Hebei Senlang Biotechnology Inc Ltd
HRAIN Biotechnology Co Ltd
Juno Therapeutics Inc
Kite Pharma Inc
Nanjing Legend Biotech Co Ltd
NantKwest Inc
Nkarta Inc
Novartis AG
Ono Pharmaceutical Co Ltd
Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Sorrento Therapeutics Inc
Takara Bio Inc
Market Segmentation (by Type)
TIL
LAK
CAR-T
TCR-T
CIK
NK
DC
Other
Market Segmentation (by Application)
Hospital
Cancer Hospital
Centers for Disease Control and Prevention
Rehabilitation Center
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Adoptive Cellular Immunotherapy Market
Overview of the regional outlook of the Adoptive Cellular Immunotherapy Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Adoptive Cellular Immunotherapy
1.2 Key Market Segments
1.2.1 Adoptive Cellular Immunotherapy Segment by Type
1.2.2 Adoptive Cellular Immunotherapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Adoptive Cellular Immunotherapy Market Overview
2.1 Global Market Overview
2.1.1 Global Adoptive Cellular Immunotherapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Adoptive Cellular Immunotherapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Adoptive Cellular Immunotherapy Market Competitive Landscape
3.1 Global Adoptive Cellular Immunotherapy Sales by Manufacturers (2019-2024)
3.2 Global Adoptive Cellular Immunotherapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Adoptive Cellular Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Adoptive Cellular Immunotherapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Adoptive Cellular Immunotherapy Sales Sites, Area Served, Product Type
3.6 Adoptive Cellular Immunotherapy Market Competitive Situation and Trends
3.6.1 Adoptive Cellular Immunotherapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Adoptive Cellular Immunotherapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Adoptive Cellular Immunotherapy Industry Chain Analysis
4.1 Adoptive Cellular Immunotherapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Adoptive Cellular Immunotherapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Adoptive Cellular Immunotherapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Adoptive Cellular Immunotherapy Sales Market Share by Type (2019-2024)
6.3 Global Adoptive Cellular Immunotherapy Market Size Market Share by Type (2019-2024)
6.4 Global Adoptive Cellular Immunotherapy Price by Type (2019-2024)
7 Adoptive Cellular Immunotherapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Adoptive Cellular Immunotherapy Market Sales by Application (2019-2024)
7.3 Global Adoptive Cellular Immunotherapy Market Size (M USD) by Application (2019-2024)
7.4 Global Adoptive Cellular Immunotherapy Sales Growth Rate by Application (2019-2024)
8 Adoptive Cellular Immunotherapy Market Segmentation by Region
8.1 Global Adoptive Cellular Immunotherapy Sales by Region
8.1.1 Global Adoptive Cellular Immunotherapy Sales by Region
8.1.2 Global Adoptive Cellular Immunotherapy Sales Market Share by Region
8.2 North America
8.2.1 North America Adoptive Cellular Immunotherapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Adoptive Cellular Immunotherapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Adoptive Cellular Immunotherapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Adoptive Cellular Immunotherapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Adoptive Cellular Immunotherapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Amgen Inc
9.1.1 Amgen Inc Adoptive Cellular Immunotherapy Basic Information
9.1.2 Amgen Inc Adoptive Cellular Immunotherapy Product Overview
9.1.3 Amgen Inc Adoptive Cellular Immunotherapy Product Market Performance
9.1.4 Amgen Inc Business Overview
9.1.5 Amgen Inc Adoptive Cellular Immunotherapy SWOT Analysis
9.1.6 Amgen Inc Recent Developments
9.2 Autolus Therapeutics Plc
9.2.1 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Basic Information
9.2.2 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Product Overview
9.2.3 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Product Market Performance
9.2.4 Autolus Therapeutics Plc Business Overview
9.2.5 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy SWOT Analysis
9.2.6 Autolus Therapeutics Plc Recent Developments
9.3 Beijing Immunochina Medical Science and Technology Co Ltd
9.3.1 Beijing Immunochina Medical Science and Technology Co Ltd Adoptive Cellular Immunotherapy Basic Information
9.3.2 Beijing Immunochina Medical Science and Technology Co Ltd Adoptive Cellular Immunotherapy Product Overview
9.3.3 Beijing Immunochina Medical Science and Technology Co Ltd Adoptive Cellular Immunotherapy Product Market Performance
9.3.4 Beijing Immunochina Medical Science and Technology Co Ltd Adoptive Cellular Immunotherapy SWOT Analysis
9.3.5 Beijing Immunochina Medical Science and Technology Co Ltd Business Overview
9.3.6 Beijing Immunochina Medical Science and Technology Co Ltd Recent Developments
9.4 Bellicum Pharmaceuticals Inc
9.4.1 Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Basic Information
9.4.2 Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Product Overview
9.4.3 Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Product Market Performance
9.4.4 Bellicum Pharmaceuticals Inc Business Overview
9.4.5 Bellicum Pharmaceuticals Inc Recent Developments
9.5 Bristol-Myers Squibb Co
9.5.1 Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Basic Information
9.5.2 Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Product Overview
9.5.3 Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Product Market Performance
9.5.4 Bristol-Myers Squibb Co Business Overview
9.5.5 Bristol-Myers Squibb Co Recent Developments
9.6 bluebird bio Inc
9.6.1 bluebird bio Inc Adoptive Cellular Immunotherapy Basic Information
9.6.2 bluebird bio Inc Adoptive Cellular Immunotherapy Product Overview
9.6.3 bluebird bio Inc Adoptive Cellular Immunotherapy Product Market Performance
9.6.4 bluebird bio Inc Business Overview
9.6.5 bluebird bio Inc Recent Developments
9.7 CARsgen Therapeutics Ltd
9.7.1 CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Basic Information
9.7.2 CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Product Overview
9.7.3 CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Product Market Performance
9.7.4 CARsgen Therapeutics Ltd Business Overview
9.7.5 CARsgen Therapeutics Ltd Recent Developments
9.8 Celgene Corp
9.8.1 Celgene Corp Adoptive Cellular Immunotherapy Basic Information
9.8.2 Celgene Corp Adoptive Cellular Immunotherapy Product Overview
9.8.3 Celgene Corp Adoptive Cellular Immunotherapy Product Market Performance
9.8.4 Celgene Corp Business Overview
9.8.5 Celgene Corp Recent Developments
9.9 Cell Medica Ltd
9.9.1 Cell Medica Ltd Adoptive Cellular Immunotherapy Basic Information
9.9.2 Cell Medica Ltd Adoptive Cellular Immunotherapy Product Overview
9.9.3 Cell Medica Ltd Adoptive Cellular Immunotherapy Product Market Performance
9.9.4 Cell Medica Ltd Business Overview
9.9.5 Cell Medica Ltd Recent Developments
9.10 Cellular Biomedicine Group Inc
9.10.1 Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Basic Information
9.10.2 Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Product Overview
9.10.3 Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Product Market Performance
9.10.4 Cellular Biomedicine Group Inc Business Overview
9.10.5 Cellular Biomedicine Group Inc Recent Developments
9.11 Celularity Inc
9.11.1 Celularity Inc Adoptive Cellular Immunotherapy Basic Information
9.11.2 Celularity Inc Adoptive Cellular Immunotherapy Product Overview
9.11.3 Celularity Inc Adoptive Cellular Immunotherapy Product Market Performance
9.11.4 Celularity Inc Business Overview
9.11.5 Celularity Inc Recent Developments
9.12 Celyad SA
9.12.1 Celyad SA Adoptive Cellular Immunotherapy Basic Information
9.12.2 Celyad SA Adoptive Cellular Immunotherapy Product Overview
9.12.3 Celyad SA Adoptive Cellular Immunotherapy Product Market Performance
9.12.4 Celyad SA Business Overview
9.12.5 Celyad SA Recent Developments
9.13 Daiichi Sankyo Co Ltd
9.13.1 Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Basic Information
9.13.2 Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Product Overview
9.13.3 Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Product Market Performance
9.13.4 Daiichi Sankyo Co Ltd Business Overview
9.13.5 Daiichi Sankyo Co Ltd Recent Developments
9.14 Fosun Pharmaceutical AG
9.14.1 Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Basic Information
9.14.2 Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Product Overview
9.14.3 Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Product Market Performance
9.14.4 Fosun Pharmaceutical AG Business Overview
9.14.5 Fosun Pharmaceutical AG Recent Developments
9.15 Gilead Sciences Inc
9.15.1 Gilead Sciences Inc Adoptive Cellular Immunotherapy Basic Information
9.15.2 Gilead Sciences Inc Adoptive Cellular Immunotherapy Product Overview
9.15.3 Gilead Sciences Inc Adoptive Cellular Immunotherapy Product Market Performance
9.15.4 Gilead Sciences Inc Business Overview
9.15.5 Gilead Sciences Inc Recent Developments
9.16 Guangzhou Anjie Biomedical Technology Co Ltd
9.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Basic Information
9.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Product Overview
9.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Product Market Performance
9.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
9.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Recent Developments
9.17 Hangzhou Converd Co Ltd
9.17.1 Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Basic Information
9.17.2 Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Product Overview
9.17.3 Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Product Market Performance
9.17.4 Hangzhou Converd Co Ltd Business Overview
9.17.5 Hangzhou Converd Co Ltd Recent Developments
9.18 Hebei Senlang Biotechnology Inc Ltd
9.18.1 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Basic Information
9.18.2 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Product Overview
9.18.3 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Product Market Performance
9.18.4 Hebei Senlang Biotechnology Inc Ltd Business Overview
9.18.5 Hebei Senlang Biotechnology Inc Ltd Recent Developments
9.19 HRAIN Biotechnology Co Ltd
9.19.1 HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Basic Information
9.19.2 HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Product Overview
9.19.3 HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Product Market Performance
9.19.4 HRAIN Biotechnology Co Ltd Business Overview
9.19.5 HRAIN Biotechnology Co Ltd Recent Developments
9.20 Juno Therapeutics Inc
9.20.1 Juno Therapeutics Inc Adoptive Cellular Immunotherapy Basic Information
9.20.2 Juno Therapeutics Inc Adoptive Cellular Immunotherapy Product Overview
9.20.3 Juno Therapeutics Inc Adoptive Cellular Immunotherapy Product Market Performance
9.20.4 Juno Therapeutics Inc Business Overview
9.20.5 Juno Therapeutics Inc Recent Developments
9.21 Kite Pharma Inc
9.21.1 Kite Pharma Inc Adoptive Cellular Immunotherapy Basic Information
9.21.2 Kite Pharma Inc Adoptive Cellular Immunotherapy Product Overview
9.21.3 Kite Pharma Inc Adoptive Cellular Immunotherapy Product Market Performance
9.21.4 Kite Pharma Inc Business Overview
9.21.5 Kite Pharma Inc Recent Developments
9.22 Nanjing Legend Biotech Co Ltd
9.22.1 Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Basic Information
9.22.2 Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Product Overview
9.22.3 Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Product Market Performance
9.22.4 Nanjing Legend Biotech Co Ltd Business Overview
9.22.5 Nanjing Legend Biotech Co Ltd Recent Developments
9.23 NantKwest Inc
9.23.1 NantKwest Inc Adoptive Cellular Immunotherapy Basic Information
9.23.2 NantKwest Inc Adoptive Cellular Immunotherapy Product Overview
9.23.3 NantKwest Inc Adoptive Cellular Immunotherapy Product Market Performance
9.23.4 NantKwest Inc Business Overview
9.23.5 NantKwest Inc Recent Developments
9.24 Nkarta Inc
9.24.1 Nkarta Inc Adoptive Cellular Immunotherapy Basic Information
9.24.2 Nkarta Inc Adoptive Cellular Immunotherapy Product Overview
9.24.3 Nkarta Inc Adoptive Cellular Immunotherapy Product Market Performance
9.24.4 Nkarta Inc Business Overview
9.24.5 Nkarta Inc Recent Developments
9.25 Novartis AG
9.25.1 Novartis AG Adoptive Cellular Immunotherapy Basic Information
9.25.2 Novartis AG Adoptive Cellular Immunotherapy Product Overview
9.25.3 Novartis AG Adoptive Cellular Immunotherapy Product Market Performance
9.25.4 Novartis AG Business Overview
9.25.5 Novartis AG Recent Developments
9.26 Ono Pharmaceutical Co Ltd
9.26.1 Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Basic Information
9.26.2 Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Product Overview
9.26.3 Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Product Market Performance
9.26.4 Ono Pharmaceutical Co Ltd Business Overview
9.26.5 Ono Pharmaceutical Co Ltd Recent Developments
9.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
9.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Basic Information
9.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Product Overview
9.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Product Market Performance
9.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
9.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Developments
9.28 Sorrento Therapeutics Inc
9.28.1 Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Basic Information
9.28.2 Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Product Overview
9.28.3 Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Product Market Performance
9.28.4 Sorrento Therapeutics Inc Business Overview
9.28.5 Sorrento Therapeutics Inc Recent Developments
9.29 Takara Bio Inc
9.29.1 Takara Bio Inc Adoptive Cellular Immunotherapy Basic Information
9.29.2 Takara Bio Inc Adoptive Cellular Immunotherapy Product Overview
9.29.3 Takara Bio Inc Adoptive Cellular Immunotherapy Product Market Performance
9.29.4 Takara Bio Inc Business Overview
9.29.5 Takara Bio Inc Recent Developments
10 Adoptive Cellular Immunotherapy Market Forecast by Region
10.1 Global Adoptive Cellular Immunotherapy Market Size Forecast
10.2 Global Adoptive Cellular Immunotherapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Adoptive Cellular Immunotherapy Market Size Forecast by Country
10.2.3 Asia Pacific Adoptive Cellular Immunotherapy Market Size Forecast by Region
10.2.4 South America Adoptive Cellular Immunotherapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Adoptive Cellular Immunotherapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Adoptive Cellular Immunotherapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Adoptive Cellular Immunotherapy by Type (2025-2030)
11.1.2 Global Adoptive Cellular Immunotherapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Adoptive Cellular Immunotherapy by Type (2025-2030)
11.2 Global Adoptive Cellular Immunotherapy Market Forecast by Application (2025-2030)
11.2.1 Global Adoptive Cellular Immunotherapy Sales (K Units) Forecast by Application
11.2.2 Global Adoptive Cellular Immunotherapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Adoptive Cellular Immunotherapy Market Size Comparison by Region (M USD)
Table 5. Global Adoptive Cellular Immunotherapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Adoptive Cellular Immunotherapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Adoptive Cellular Immunotherapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Adoptive Cellular Immunotherapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cellular Immunotherapy as of 2022)
Table 10. Global Market Adoptive Cellular Immunotherapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Adoptive Cellular Immunotherapy Sales Sites and Area Served
Table 12. Manufacturers Adoptive Cellular Immunotherapy Product Type
Table 13. Global Adoptive Cellular Immunotherapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Adoptive Cellular Immunotherapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Adoptive Cellular Immunotherapy Market Challenges
Table 22. Global Adoptive Cellular Immunotherapy Sales by Type (K Units)
Table 23. Global Adoptive Cellular Immunotherapy Market Size by Type (M USD)
Table 24. Global Adoptive Cellular Immunotherapy Sales (K Units) by Type (2019-2024)
Table 25. Global Adoptive Cellular Immunotherapy Sales Market Share by Type (2019-2024)
Table 26. Global Adoptive Cellular Immunotherapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Adoptive Cellular Immunotherapy Market Size Share by Type (2019-2024)
Table 28. Global Adoptive Cellular Immunotherapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global Adoptive Cellular Immunotherapy Sales (K Units) by Application
Table 30. Global Adoptive Cellular Immunotherapy Market Size by Application
Table 31. Global Adoptive Cellular Immunotherapy Sales by Application (2019-2024) & (K Units)
Table 32. Global Adoptive Cellular Immunotherapy Sales Market Share by Application (2019-2024)
Table 33. Global Adoptive Cellular Immunotherapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Adoptive Cellular Immunotherapy Market Share by Application (2019-2024)
Table 35. Global Adoptive Cellular Immunotherapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Adoptive Cellular Immunotherapy Sales by Region (2019-2024) & (K Units)
Table 37. Global Adoptive Cellular Immunotherapy Sales Market Share by Region (2019-2024)
Table 38. North America Adoptive Cellular Immunotherapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe Adoptive Cellular Immunotherapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Adoptive Cellular Immunotherapy Sales by Region (2019-2024) & (K Units)
Table 41. South America Adoptive Cellular Immunotherapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Adoptive Cellular Immunotherapy Sales by Region (2019-2024) & (K Units)
Table 43. Amgen Inc Adoptive Cellular Immunotherapy Basic Information
Table 44. Amgen Inc Adoptive Cellular Immunotherapy Product Overview
Table 45. Amgen Inc Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Amgen Inc Business Overview
Table 47. Amgen Inc Adoptive Cellular Immunotherapy SWOT Analysis
Table 48. Amgen Inc Recent Developments
Table 49. Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Basic Information
Table 50. Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Product Overview
Table 51. Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Autolus Therapeutics Plc Business Overview
Table 53. Autolus Therapeutics Plc Adoptive Cellular Immunotherapy SWOT Analysis
Table 54. Autolus Therapeutics Plc Recent Developments
Table 55. Beijing Immunochina Medical Science and Technology Co Ltd Adoptive Cellular Immunotherapy Basic Information
Table 56. Beijing Immunochina Medical Science and Technology Co Ltd Adoptive Cellular Immunotherapy Product Overview
Table 57. Beijing Immunochina Medical Science and Technology Co Ltd Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Beijing Immunochina Medical Science and Technology Co Ltd Adoptive Cellular Immunotherapy SWOT Analysis
Table 59. Beijing Immunochina Medical Science and Technology Co Ltd Business Overview
Table 60. Beijing Immunochina Medical Science and Technology Co Ltd Recent Developments
Table 61. Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Basic Information
Table 62. Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Product Overview
Table 63. Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Bellicum Pharmaceuticals Inc Business Overview
Table 65. Bellicum Pharmaceuticals Inc Recent Developments
Table 66. Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Basic Information
Table 67. Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Product Overview
Table 68. Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Bristol-Myers Squibb Co Business Overview
Table 70. Bristol-Myers Squibb Co Recent Developments
Table 71. bluebird bio Inc Adoptive Cellular Immunotherapy Basic Information
Table 72. bluebird bio Inc Adoptive Cellular Immunotherapy Product Overview
Table 73. bluebird bio Inc Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. bluebird bio Inc Business Overview
Table 75. bluebird bio Inc Recent Developments
Table 76. CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Basic Information
Table 77. CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Product Overview
Table 78. CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. CARsgen Therapeutics Ltd Business Overview
Table 80. CARsgen Therapeutics Ltd Recent Developments
Table 81. Celgene Corp Adoptive Cellular Immunotherapy Basic Information
Table 82. Celgene Corp Adoptive Cellular Immunotherapy Product Overview
Table 83. Celgene Corp Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Celgene Corp Business Overview
Table 85. Celgene Corp Recent Developments
Table 86. Cell Medica Ltd Adoptive Cellular Immunotherapy Basic Information
Table 87. Cell Medica Ltd Adoptive Cellular Immunotherapy Product Overview
Table 88. Cell Medica Ltd Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Cell Medica Ltd Business Overview
Table 90. Cell Medica Ltd Recent Developments
Table 91. Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Basic Information
Table 92. Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Product Overview
Table 93. Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Cellular Biomedicine Group Inc Business Overview
Table 95. Cellular Biomedicine Group Inc Recent Developments
Table 96. Celularity Inc Adoptive Cellular Immunotherapy Basic Information
Table 97. Celularity Inc Adoptive Cellular Immunotherapy Product Overview
Table 98. Celularity Inc Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Celularity Inc Business Overview
Table 100. Celularity Inc Recent Developments
Table 101. Celyad SA Adoptive Cellular Immunotherapy Basic Information
Table 102. Celyad SA Adoptive Cellular Immunotherapy Product Overview
Table 103. Celyad SA Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Celyad SA Business Overview
Table 105. Celyad SA Recent Developments
Table 106. Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Basic Information
Table 107. Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Product Overview
Table 108. Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Daiichi Sankyo Co Ltd Business Overview
Table 110. Daiichi Sankyo Co Ltd Recent Developments
Table 111. Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Basic Information
Table 112. Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Product Overview
Table 113. Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Fosun Pharmaceutical AG Business Overview
Table 115. Fosun Pharmaceutical AG Recent Developments
Table 116. Gilead Sciences Inc Adoptive Cellular Immunotherapy Basic Information
Table 117. Gilead Sciences Inc Adoptive Cellular Immunotherapy Product Overview
Table 118. Gilead Sciences Inc Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Gilead Sciences Inc Business Overview
Table 120. Gilead Sciences Inc Recent Developments
Table 121. Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Basic Information
Table 122. Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Product Overview
Table 123. Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
Table 125. Guangzhou Anjie Biomedical Technology Co Ltd Recent Developments
Table 126. Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Basic Information
Table 127. Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Product Overview
Table 128. Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Hangzhou Converd Co Ltd Business Overview
Table 130. Hangzhou Converd Co Ltd Recent Developments
Table 131. Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Basic Information
Table 132. Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Product Overview
Table 133. Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Hebei Senlang Biotechnology Inc Ltd Business Overview
Table 135. Hebei Senlang Biotechnology Inc Ltd Recent Developments
Table 136. HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Basic Information
Table 137. HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Product Overview
Table 138. HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. HRAIN Biotechnology Co Ltd Business Overview
Table 140. HRAIN Biotechnology Co Ltd Recent Developments
Table 141. Juno Therapeutics Inc Adoptive Cellular Immunotherapy Basic Information
Table 142. Juno Therapeutics Inc Adoptive Cellular Immunotherapy Product Overview
Table 143. Juno Therapeutics Inc Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Juno Therapeutics Inc Business Overview
Table 145. Juno Therapeutics Inc Recent Developments
Table 146. Kite Pharma Inc Adoptive Cellular Immunotherapy Basic Information
Table 147. Kite Pharma Inc Adoptive Cellular Immunotherapy Product Overview
Table 148. Kite Pharma Inc Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Kite Pharma Inc Business Overview
Table 150. Kite Pharma Inc Recent Developments
Table 151. Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Basic Information
Table 152. Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Product Overview
Table 153. Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. Nanjing Legend Biotech Co Ltd Business Overview
Table 155. Nanjing Legend Biotech Co Ltd Recent Developments
Table 156. NantKwest Inc Adoptive Cellular Immunotherapy Basic Information
Table 157. NantKwest Inc Adoptive Cellular Immunotherapy Product Overview
Table 158. NantKwest Inc Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. NantKwest Inc Business Overview
Table 160. NantKwest Inc Recent Developments
Table 161. Nkarta Inc Adoptive Cellular Immunotherapy Basic Information
Table 162. Nkarta Inc Adoptive Cellular Immunotherapy Product Overview
Table 163. Nkarta Inc Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 164. Nkarta Inc Business Overview
Table 165. Nkarta Inc Recent Developments
Table 166. Novartis AG Adoptive Cellular Immunotherapy Basic Information
Table 167. Novartis AG Adoptive Cellular Immunotherapy Product Overview
Table 168. Novartis AG Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 169. Novartis AG Business Overview
Table 170. Novartis AG Recent Developments
Table 171. Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Basic Information
Table 172. Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Product Overview
Table 173. Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 174. Ono Pharmaceutical Co Ltd Business Overview
Table 175. Ono Pharmaceutical Co Ltd Recent Developments
Table 176. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Basic Information
Table 177. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Product Overview
Table 178. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 179. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
Table 180. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Developments
Table 181. Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Basic Information
Table 182. Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Product Overview
Table 183. Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 184. Sorrento Therapeutics Inc Business Overview
Table 185. Sorrento Therapeutics Inc Recent Developments
Table 186. Takara Bio Inc Adoptive Cellular Immunotherapy Basic Information
Table 187. Takara Bio Inc Adoptive Cellular Immunotherapy Product Overview
Table 188. Takara Bio Inc Adoptive Cellular Immunotherapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 189. Takara Bio Inc Business Overview
Table 190. Takara Bio Inc Recent Developments
Table 191. Global Adoptive Cellular Immunotherapy Sales Forecast by Region (2025-2030) & (K Units)
Table 192. Global Adoptive Cellular Immunotherapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 193. North America Adoptive Cellular Immunotherapy Sales Forecast by Country (2025-2030) & (K Units)
Table 194. North America Adoptive Cellular Immunotherapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 195. Europe Adoptive Cellular Immunotherapy Sales Forecast by Country (2025-2030) & (K Units)
Table 196. Europe Adoptive Cellular Immunotherapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 197. Asia Pacific Adoptive Cellular Immunotherapy Sales Forecast by Region (2025-2030) & (K Units)
Table 198. Asia Pacific Adoptive Cellular Immunotherapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 199. South America Adoptive Cellular Immunotherapy Sales Forecast by Country (2025-2030) & (K Units)
Table 200. South America Adoptive Cellular Immunotherapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 201. Middle East and Africa Adoptive Cellular Immunotherapy Consumption Forecast by Country (2025-2030) & (Units)
Table 202. Middle East and Africa Adoptive Cellular Immunotherapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 203. Global Adoptive Cellular Immunotherapy Sales Forecast by Type (2025-2030) & (K Units)
Table 204. Global Adoptive Cellular Immunotherapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 205. Global Adoptive Cellular Immunotherapy Price Forecast by Type (2025-2030) & (USD/Unit)
Table 206. Global Adoptive Cellular Immunotherapy Sales (K Units) Forecast by Application (2025-2030)
Table 207. Global Adoptive Cellular Immunotherapy Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Adoptive Cellular Immunotherapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Adoptive Cellular Immunotherapy Market Size (M USD), 2019-2030
Figure 5. Global Adoptive Cellular Immunotherapy Market Size (M USD) (2019-2030)
Figure 6. Global Adoptive Cellular Immunotherapy Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Adoptive Cellular Immunotherapy Market Size by Country (M USD)
Figure 11. Adoptive Cellular Immunotherapy Sales Share by Manufacturers in 2023
Figure 12. Global Adoptive Cellular Immunotherapy Revenue Share by Manufacturers in 2023
Figure 13. Adoptive Cellular Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Adoptive Cellular Immunotherapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Adoptive Cellular Immunotherapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Adoptive Cellular Immunotherapy Market Share by Type
Figure 18. Sales Market Share of Adoptive Cellular Immunotherapy by Type (2019-2024)
Figure 19. Sales Market Share of Adoptive Cellular Immunotherapy by Type in 2023
Figure 20. Market Size Share of Adoptive Cellular Immunotherapy by Type (2019-2024)
Figure 21. Market Size Market Share of Adoptive Cellular Immunotherapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Adoptive Cellular Immunotherapy Market Share by Application
Figure 24. Global Adoptive Cellular Immunotherapy Sales Market Share by Application (2019-2024)
Figure 25. Global Adoptive Cellular Immunotherapy Sales Market Share by Application in 2023
Figure 26. Global Adoptive Cellular Immunotherapy Market Share by Application (2019-2024)
Figure 27. Global Adoptive Cellular Immunotherapy Market Share by Application in 2023
Figure 28. Global Adoptive Cellular Immunotherapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Adoptive Cellular Immunotherapy Sales Market Share by Region (2019-2024)
Figure 30. North America Adoptive Cellular Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Adoptive Cellular Immunotherapy Sales Market Share by Country in 2023
Figure 32. U.S. Adoptive Cellular Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Adoptive Cellular Immunotherapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Adoptive Cellular Immunotherapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Adoptive Cellular Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Adoptive Cellular Immunotherapy Sales Market Share by Country in 2023
Figure 37. Germany Adoptive Cellular Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Adoptive Cellular Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Adoptive Cellular Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Adoptive Cellular Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Adoptive Cellular Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Adoptive Cellular Immunotherapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Adoptive Cellular Immunotherapy Sales Market Share by Region in 2023
Figure 44. China Adoptive Cellular Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Adoptive Cellular Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Adoptive Cellular Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Adoptive Cellular Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Adoptive Cellular Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Adoptive Cellular Immunotherapy Sales and Growth Rate (K Units)
Figure 50. South America Adoptive Cellular Immunotherapy Sales Market Share by Country in 2023
Figure 51. Brazil Adoptive Cellular Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Adoptive Cellular Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Adoptive Cellular Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Adoptive Cellular Immunotherapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Adoptive Cellular Immunotherapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Adoptive Cellular Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Adoptive Cellular Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Adoptive Cellular Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Adoptive Cellular Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Adoptive Cellular Immunotherapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Adoptive Cellular Immunotherapy Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Adoptive Cellular Immunotherapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Adoptive Cellular Immunotherapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Adoptive Cellular Immunotherapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Adoptive Cellular Immunotherapy Sales Forecast by Application (2025-2030)
Figure 66. Global Adoptive Cellular Immunotherapy Market Share Forecast by Application (2025-2030)
